CXCR4 and small cell lung carcinoma: A previous study showed that SCLC patients with urokinase-type plasminogen activator receptor (uPAR) and CXCR4 coexpression had shorter OS than those with single and co-negative uPAR or CXCR4 expression (P = 0.033) [20].